EVMN Evommune, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $276.9M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $70.0M | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $2.3M |
| 2026-Q3 | $146.3K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$70.2M6 buy days
Sold$2.3M8 sell days
Net insider flow+$67.9Mnet buying · 5 years
Latest trade2026-07-08Carver Kyle
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | Buy | Carver Kyle | CFO | 1,000 | $13.26 | $13.3K | 1 |
| 2026-07-07 | Buy | KIRSCH ARTHUR S | Director | 10,000 | $13.30 | $133.0K | 1 |
| 2026-06-22 | Sell | Drew Janice Suzann | Other C-suite | 20,000 | $22.63 | $452.6K | 1 |
| 2026-06-22 | Sell | Pena Luis C. | CEO | 7,438 | $22.71 | $168.9K | 1 |
| 2026-06-22 | Sell | Patel Jeegar Pravinkumar | Other C-suite | 1,488 | $22.50 | $33.5K | 1 |
| 2026-06-02 | Sell | Cohen David E | Director | 6,056 | $20.33 | $123.1K | 2 |
| 2026-06-01 | Sell | Pena Luis C. | CEO | 16,787 | $22.74 | $381.7K | 1 |
| 2026-06-01 | Sell | Patel Jeegar Pravinkumar | Other C-suite | 16,687 | $22.74 | $379.5K | 1 |
| 2026-05-28 | Sell | Carver Kyle | CFO | 18,175 | $22.84 | $415.1K | 1 |
| 2026-05-28 | Sell | Moss Gregory S. | Other C-suite | 14,223 | $22.83 | $324.7K | 1 |
| 2025-12-19 | Buy | Hopfner Robert Lorne | Director | 1,000 | $17.35 | $17.4K | 1 |
| 2025-11-07 | Buy | LSP 7 Cooperative UA | 10% owner | 1,562,500 | $16.00 | $25.0M | 1 |
| 2025-11-07 | Buy | Verduyn-van Weegen Felice Isabel | Director | 1,562,500 | $16.00 | $25.0M | 1 |
| 2025-11-07 | Buy | RA CAPITAL MANAGEMENT, L.P. | Director | 1,250,000 | $16.00 | $20.0M | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| LSP 7 Cooperative UA | 10% owner | $25.0M | $0 | 2025-11-07 |
| Verduyn-van Weegen Felice Isabel | Director | $25.0M | $0 | 2025-11-07 |
| RA CAPITAL MANAGEMENT, L.P. | Director | $20.0M | $0 | 2025-11-07 |
| Pena Luis C. | CEO | $0 | $550.7K | 2026-06-22 |
| Drew Janice Suzann | Other C-suite | $0 | $452.6K | 2026-06-22 |
| Carver Kyle | CFO | $13.3K | $415.1K | 2026-07-08 |
| Patel Jeegar Pravinkumar | Other C-suite | $0 | $412.9K | 2026-06-22 |
| Moss Gregory S. | Other C-suite | $0 | $324.7K | 2026-05-28 |
| KIRSCH ARTHUR S | Director | $133.0K | $0 | 2026-07-07 |
| Cohen David E | Director | $0 | $123.1K | 2026-06-02 |
| Hopfner Robert Lorne | Director | $17.4K | $0 | 2025-12-19 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-11-07 | 3 | $70.0M | 45 | -11.0% (-11.0% raw) | +56.9% (+57.5% raw) | +1.3% (+10.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.